Cancel
Lucence Health
Lucence Health Employees
4 people indexed:
-
93pp.2b8zx48@9700t75.p5q Sign up to see email
-
xsq03dvg.fgv@kid3yv1.6gr Sign up to see email
-
94bv7r7.pfp@27yj7j9.915 Sign up to see email
-
1a08i.@9pv2xib.gy7 Sign up to see email
Lucence Health Company Information
Lucence Health, headquartered in Palo Alto, California, is a biotechnology firm that focuses on the early detection of cancer through sensitive blood-testing technologies. The company offers LiquidHALLMARK, a liquid biopsy test that profiles cancer by analyzing both circulating DNA and RNA from a single blood draw. This test can detect mutations in 80 genes, fusions in 10 genes, and somatic variants, and includes the option to analyze 36 ctRNA targets. Lucence Health also develops proprietary technologies such as AmpliMark, which boasts over 99% sensitivity in detecting clinically relevant biomarkers for lung, breast, and blood cancers. In addition to its headquarters, Lucence Health operates offices in Singapore, Hong Kong, and Suzhou, China. The company showcased its innovative liquid biopsy technology at the 2023 ASCO Annual Meeting, emphasizing its commitment to enhancing cancer diagnostics.
Report inaccurate information
Report inaccurate information
